Clinical Trial Update: Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands [Phase 2]

View source ↗

Summary

Extension study update for Ionis-GHR-LRx in acromegaly patients on long-acting somatostatin receptor ligands; Phase 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• IONIS-GHR-LRx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Acromegaly | Phase 2 | Status: COMPLETED